Skandinaviska Enskilda Banken Ab (Publ) Ionis Pharmaceuticals Inc Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 59,626 shares of IONS stock, worth $1.77 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
59,626
Previous 59,626
-0.0%
Holding current value
$1.77 Million
Previous $2.39 Million
12.73%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding IONS
# of Institutions
409Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$489 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$421 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$341 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$307 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$234 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.22B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...